Optos, PLC
Clinical trials sponsored by Optos, PLC, explained in plain language.
Ophthalmic imaging device manufacturer (acquired by Nikon, delisted).
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a modified camera capture better images of diseased retinas? Results expected Oct 2026 (estimated)
-
New eye camera tested for glaucoma detection
Diagnosis CompletedThis study tested a new imaging device called the P200TE on 53 people with glaucoma. The goal was simply to see how well it could capture images of the back of the eye. It was not a treatment study, so there were no health benefits or risks for participants.
Sponsor: Optos, PLC • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
Can a new eye scanner set the standard for healthy vision?
Knowledge-focused CompletedResearchers are collecting detailed eye images from about 954 healthy adults aged 22 and older to build a reference database for the Optos P200TE, an eye imaging device. The study measures retinal thickness, nerve fiber layer, and optic nerve head dimensions using OCT scans. The …
Sponsor: Optos, PLC • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
New eye scanner aims to sharpen view of retinal disease
Knowledge-focused CompletedThis trial tests a new device called P200TxE that takes detailed images of the back of the eye. Researchers want to see how well it captures images in people with retinal diseases like glaucoma or macular degeneration. The study involves adults aged 22 and older who have been dia…
Sponsor: Optos, PLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC